Current realities of Wilms tumor burden and therapy in Ghana
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION(2023)
Abstract
Background
Between 2005-2014, Ghana’s Wilms tumor (WT) 2-year disease-free survival of 44% trailed behind high-income countries. This study aimed to uncover social determinants of health leading to preventable WT death in Ghana.
Methods
WT patient records (2014-2022) at Korle-Bu Teaching Hospital (KBTH; Ghana) were reviewed retrospectively. Demographics, clinical course, tumor characteristics, and survival were evaluated using t-tests, Pearson Chi-square, and multivariate Cox logistic regression.
Results
Of 127 patients identified, 65 were female. Median age was 44 months [IQR 25-66]. Forty-eight patients (38%) presented with distant metastasis (75% lung, 25% liver), which associated with hypoalbuminemia (p=0.009), caregiver informal employment (p=0.04), and larger tumors (p=0.002). Despite neoadjuvant chemotherapy shrinking 84% of tumors, larger initial size associated with incomplete resection (p=0.046). Of 110 nephrectomies, 31 patients had residual disease, negatively impacting survival (p=2.7x10-5). Twenty-two patients (17%) abandoned treatment (45% before nephrectomy; 55% after nephrectomy), with seven patients ultimately lost to follow-up (LTFU). Decedents represented 43% of stage IV patients compared to 28% in other stages. Event-free survival (EFS) was 60% at 4 years with overall survival (OS) at 67%.
Conclusions
Although Ghana’s WT survival has improved, informal employment and distance from KBTH predisposed patients to delayed referral, greater tumor burden, hypoalbuminemia, and lower survival.
Level of Evidence
II
MoreTranslated text
Key words
Wilms tumor,Social determinants of health,Survival
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined